Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2018
Price : $35 *
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Rett syndrome
- Focus Therapeutic Use
- 04 Oct 2018 Status changed from active, no longer recruiting to completed.
- 20 Apr 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Aug 2014 as reported by ClinicalTrials.gov record.
- 20 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.